Clinical supply management (CSM) is a crucial process in the success of clinical trials. It encompasses the planning, procurement, storage, distribution, and accountability of investigational medical products (IMPs) throughout the trial period.
The global Clinical Supply Management market size is projected to grow from US$ 2025 million in 2023 to US$ 3421.3 million in 2030; it is expected to grow at a CAGR of 7.8% from 2024 to 2030.
The 鈥淐linical Supply Management Industry Forecast鈥� looks at past sales and reviews total world Clinical Supply Management sales in 2023, providing a comprehensive analysis by region and market sector of projected Clinical Supply Management sales for 2024 through 2030. With Clinical Supply Management sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Clinical Supply Management industry.
This Insight Report provides a comprehensive analysis of the global Clinical Supply Management landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Clinical Supply Management portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Clinical Supply Management market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Clinical Supply Management and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Clinical Supply Management.
Clinical Supply Management 麻豆原创: Thriving on Growing Clinical Trial Activity and Technological Advancements
The global Clinical Supply Management (CSM) market is projected to experience significant growth in the coming years, driven by several key factors:
麻豆原创 Drivers:
Rising demand for clinical trials: Increasing investment in pharmaceutical research and development is leading to a higher number of clinical trials being conducted, driving the demand for efficient Clinical Supply Management solutions.
Growing complexity of clinical trials: Clinical trials are becoming increasingly complex with larger patient populations, geographically dispersed sites, and more diverse study designs. This complexity necessitates advanced Clinical Supply Management tools and technologies to manage the supply chain effectively.
Stringent regulatory requirements: Regulatory agencies like the FDA and EMA are imposing stricter requirements on the handling and distribution of IMPs, requiring robust Clinical Supply Management systems to ensure compliance.
Evolving technological landscape: Advancements in automation, data analytics, and cloud computing are offering innovative solutions for improving the efficiency and accuracy of Clinical Supply Management processes.
Growing focus on patient-centricity: The industry is increasingly focusing on patient-centric approaches, and Clinical Supply Management solutions are evolving to integrate patient portals and mobile apps for improved communication and engagement.
麻豆原创 Trends:
Integration of automation and data analytics: Clinical Supply Management solutions are increasingly incorporating automation for tasks like ordering, tracking, and reporting, and utilizing data analytics for optimizing inventory management and predicting future demand.
Focus on patient-centricity: Patient portals and mobile apps are being integrated into Clinical Supply Management systems to improve communication, engagement, and adherence to medication schedules.
Globalization of clinical trials: As clinical trials become increasingly global, Clinical Supply Management solutions need to adapt to different regulatory requirements and logistical challenges.
Rise of digital health technologies: Wearable devices and other digital health technologies are being integrated with Clinical Supply Management systems to collect real-world data and provide valuable insights into patient outcomes.
Sustainability initiatives: The industry is focusing on developing sustainable solutions for packaging, storage, and distribution of IMPs to minimize environmental impact.
Challenges and Opportunities:
High initial cost of implementation: Implementing advanced Clinical Supply Managementsolutions can be expensive, especially for smaller organizations.
Data security and privacy concerns: Ensuring data security and privacy in Clinical Supply Management systems is a critical challenge for vendors and users.
Rapidly evolving regulatory landscape: Keeping pace with the evolving regulatory landscape can be complex and time-consuming.
Competition from new entrants: The market is becoming increasingly competitive with the entry of new players, offering innovative and cost-effective solutions.
The future of the Clinical Supply Management market is bright. As the clinical trial landscape continues to evolve and demand for efficient and patient-centric solutions increases, the market is expected to experience significant growth. By addressing the challenges and capitalizing on the opportunities, Clinical Supply Management vendors can position themselves for continued success in this dynamic and growing market.
This report presents a comprehensive overview, market shares, and growth opportunities of Clinical Supply Management market by product type, application, key players and key regions and countries.
Segmentation by type
Software
Services
Segmentation by application
Pharma and Biopharmaceutical
Medical Device
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
SAP
Contract Pharma
Parexel
Almac Group
Catalent Pharma Solutions
Piramal Pharma Solutions
Klifo A/S.
Nomeco A/S
Clinigen Clinical Supplies Management
ICON
Endpoint Clinical
PPD Inc
Yprime
Fervor Clinical Supplies Management
Patheon Pharma Services
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Clinical Supply Management 麻豆原创 Size 2019-2030
2.1.2 Clinical Supply Management 麻豆原创 Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Clinical Supply Management Segment by Type
2.2.1 Software
2.2.2 Services
2.3 Clinical Supply Management 麻豆原创 Size by Type
2.3.1 Clinical Supply Management 麻豆原创 Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Clinical Supply Management 麻豆原创 Size 麻豆原创 Share by Type (2019-2024)
2.4 Clinical Supply Management Segment by Application
2.4.1 Pharma and Biopharmaceutical
2.4.2 Medical Device
2.4.3 Other
2.5 Clinical Supply Management 麻豆原创 Size by Application
2.5.1 Clinical Supply Management 麻豆原创 Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Clinical Supply Management 麻豆原创 Size 麻豆原创 Share by Application (2019-2024)
3 Clinical Supply Management 麻豆原创 Size by Player
3.1 Clinical Supply Management 麻豆原创 Size 麻豆原创 Share by Players
3.1.1 Global Clinical Supply Management Revenue by Players (2019-2024)
3.1.2 Global Clinical Supply Management Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Clinical Supply Management Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Clinical Supply Management by Regions
4.1 Clinical Supply Management 麻豆原创 Size by Regions (2019-2024)
4.2 Americas Clinical Supply Management 麻豆原创 Size Growth (2019-2024)
4.3 APAC Clinical Supply Management 麻豆原创 Size Growth (2019-2024)
4.4 Europe Clinical Supply Management 麻豆原创 Size Growth (2019-2024)
4.5 Middle East & Africa Clinical Supply Management 麻豆原创 Size Growth (2019-2024)
5 Americas
5.1 Americas Clinical Supply Management 麻豆原创 Size by Country (2019-2024)
5.2 Americas Clinical Supply Management 麻豆原创 Size by Type (2019-2024)
5.3 Americas Clinical Supply Management 麻豆原创 Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Clinical Supply Management 麻豆原创 Size by Region (2019-2024)
6.2 APAC Clinical Supply Management 麻豆原创 Size by Type (2019-2024)
6.3 APAC Clinical Supply Management 麻豆原创 Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Clinical Supply Management by Country (2019-2024)
7.2 Europe Clinical Supply Management 麻豆原创 Size by Type (2019-2024)
7.3 Europe Clinical Supply Management 麻豆原创 Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Clinical Supply Management by Region (2019-2024)
8.2 Middle East & Africa Clinical Supply Management 麻豆原创 Size by Type (2019-2024)
8.3 Middle East & Africa Clinical Supply Management 麻豆原创 Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Clinical Supply Management 麻豆原创 Forecast
10.1 Global Clinical Supply Management Forecast by Regions (2025-2030)
10.1.1 Global Clinical Supply Management Forecast by Regions (2025-2030)
10.1.2 Americas Clinical Supply Management Forecast
10.1.3 APAC Clinical Supply Management Forecast
10.1.4 Europe Clinical Supply Management Forecast
10.1.5 Middle East & Africa Clinical Supply Management Forecast
10.2 Americas Clinical Supply Management Forecast by Country (2025-2030)
10.2.1 United States Clinical Supply Management 麻豆原创 Forecast
10.2.2 Canada Clinical Supply Management 麻豆原创 Forecast
10.2.3 Mexico Clinical Supply Management 麻豆原创 Forecast
10.2.4 Brazil Clinical Supply Management 麻豆原创 Forecast
10.3 APAC Clinical Supply Management Forecast by Region (2025-2030)
10.3.1 China Clinical Supply Management 麻豆原创 Forecast
10.3.2 Japan Clinical Supply Management 麻豆原创 Forecast
10.3.3 Korea Clinical Supply Management 麻豆原创 Forecast
10.3.4 Southeast Asia Clinical Supply Management 麻豆原创 Forecast
10.3.5 India Clinical Supply Management 麻豆原创 Forecast
10.3.6 Australia Clinical Supply Management 麻豆原创 Forecast
10.4 Europe Clinical Supply Management Forecast by Country (2025-2030)
10.4.1 Germany Clinical Supply Management 麻豆原创 Forecast
10.4.2 France Clinical Supply Management 麻豆原创 Forecast
10.4.3 UK Clinical Supply Management 麻豆原创 Forecast
10.4.4 Italy Clinical Supply Management 麻豆原创 Forecast
10.4.5 Russia Clinical Supply Management 麻豆原创 Forecast
10.5 Middle East & Africa Clinical Supply Management Forecast by Region (2025-2030)
10.5.1 Egypt Clinical Supply Management 麻豆原创 Forecast
10.5.2 South Africa Clinical Supply Management 麻豆原创 Forecast
10.5.3 Israel Clinical Supply Management 麻豆原创 Forecast
10.5.4 Turkey Clinical Supply Management 麻豆原创 Forecast
10.5.5 GCC Countries Clinical Supply Management 麻豆原创 Forecast
10.6 Global Clinical Supply Management Forecast by Type (2025-2030)
10.7 Global Clinical Supply Management Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 SAP
11.1.1 SAP Company Information
11.1.2 SAP Clinical Supply Management Product Offered
11.1.3 SAP Clinical Supply Management Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.1.4 SAP Main Business Overview
11.1.5 SAP Latest Developments
11.2 Contract Pharma
11.2.1 Contract Pharma Company Information
11.2.2 Contract Pharma Clinical Supply Management Product Offered
11.2.3 Contract Pharma Clinical Supply Management Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.2.4 Contract Pharma Main Business Overview
11.2.5 Contract Pharma Latest Developments
11.3 Parexel
11.3.1 Parexel Company Information
11.3.2 Parexel Clinical Supply Management Product Offered
11.3.3 Parexel Clinical Supply Management Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.3.4 Parexel Main Business Overview
11.3.5 Parexel Latest Developments
11.4 Almac Group
11.4.1 Almac Group Company Information
11.4.2 Almac Group Clinical Supply Management Product Offered
11.4.3 Almac Group Clinical Supply Management Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.4.4 Almac Group Main Business Overview
11.4.5 Almac Group Latest Developments
11.5 Catalent Pharma Solutions
11.5.1 Catalent Pharma Solutions Company Information
11.5.2 Catalent Pharma Solutions Clinical Supply Management Product Offered
11.5.3 Catalent Pharma Solutions Clinical Supply Management Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.5.4 Catalent Pharma Solutions Main Business Overview
11.5.5 Catalent Pharma Solutions Latest Developments
11.6 Piramal Pharma Solutions
11.6.1 Piramal Pharma Solutions Company Information
11.6.2 Piramal Pharma Solutions Clinical Supply Management Product Offered
11.6.3 Piramal Pharma Solutions Clinical Supply Management Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.6.4 Piramal Pharma Solutions Main Business Overview
11.6.5 Piramal Pharma Solutions Latest Developments
11.7 Klifo A/S.
11.7.1 Klifo A/S. Company Information
11.7.2 Klifo A/S. Clinical Supply Management Product Offered
11.7.3 Klifo A/S. Clinical Supply Management Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.7.4 Klifo A/S. Main Business Overview
11.7.5 Klifo A/S. Latest Developments
11.8 Nomeco A/S
11.8.1 Nomeco A/S Company Information
11.8.2 Nomeco A/S Clinical Supply Management Product Offered
11.8.3 Nomeco A/S Clinical Supply Management Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.8.4 Nomeco A/S Main Business Overview
11.8.5 Nomeco A/S Latest Developments
11.9 Clinigen Clinical Supplies Management
11.9.1 Clinigen Clinical Supplies Management Company Information
11.9.2 Clinigen Clinical Supplies Management Clinical Supply Management Product Offered
11.9.3 Clinigen Clinical Supplies Management Clinical Supply Management Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.9.4 Clinigen Clinical Supplies Management Main Business Overview
11.9.5 Clinigen Clinical Supplies Management Latest Developments
11.10 ICON
11.10.1 ICON Company Information
11.10.2 ICON Clinical Supply Management Product Offered
11.10.3 ICON Clinical Supply Management Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.10.4 ICON Main Business Overview
11.10.5 ICON Latest Developments
11.11 Endpoint Clinical
11.11.1 Endpoint Clinical Company Information
11.11.2 Endpoint Clinical Clinical Supply Management Product Offered
11.11.3 Endpoint Clinical Clinical Supply Management Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.11.4 Endpoint Clinical Main Business Overview
11.11.5 Endpoint Clinical Latest Developments
11.12 PPD Inc
11.12.1 PPD Inc Company Information
11.12.2 PPD Inc Clinical Supply Management Product Offered
11.12.3 PPD Inc Clinical Supply Management Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.12.4 PPD Inc Main Business Overview
11.12.5 PPD Inc Latest Developments
11.13 Yprime
11.13.1 Yprime Company Information
11.13.2 Yprime Clinical Supply Management Product Offered
11.13.3 Yprime Clinical Supply Management Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.13.4 Yprime Main Business Overview
11.13.5 Yprime Latest Developments
11.14 Fervor Clinical Supplies Management
11.14.1 Fervor Clinical Supplies Management Company Information
11.14.2 Fervor Clinical Supplies Management Clinical Supply Management Product Offered
11.14.3 Fervor Clinical Supplies Management Clinical Supply Management Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.14.4 Fervor Clinical Supplies Management Main Business Overview
11.14.5 Fervor Clinical Supplies Management Latest Developments
11.15 Patheon Pharma Services
11.15.1 Patheon Pharma Services Company Information
11.15.2 Patheon Pharma Services Clinical Supply Management Product Offered
11.15.3 Patheon Pharma Services Clinical Supply Management Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.15.4 Patheon Pharma Services Main Business Overview
11.15.5 Patheon Pharma Services Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.
